Loading organizations...
Loading organizations...
Manufacturer of artificial heart valves and annuloplasty rings.
KingstronBio has raised $66.1M across 2 funding rounds.
KingstronBio has raised $66.1M in total across 2 funding rounds.
KingstronBio has raised $66.1M in total across 2 funding rounds.
KingstronBio's investors include Lu Xiaobao, Guangfa Qianhe, Panglin Investment, Shenzhen Salubris Pharmaceuticals.
KingstronBio has raised $66.1M across 2 funding rounds. Most recently, it raised $47.0M Series C in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 20, 2021 | $47.0M Series C | Lu Xiaobao | Guangfa Qianhe, Panglin Investment |
| Jan 1, 2021 | $19.2M Series B | Shenzhen Salubris Pharmaceuticals |